Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Tops Revenue Estimates

Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.03%. A quarter ago, it was expected that this company would post a loss of $0.34 per share when it actually produced a loss of $0.25, delivering a surprise of 26.47%.Over the last four quarters, the company has surp ...